Central pain syndrome is a neurological condition in which damage to the brain or spinal cord produces chronic pain that persists long after the original injury has healed. Unlike ordinary pain, which signals tissue damage at a specific site, central pain arises from the nervous system itself misfiring. It most commonly follows a stroke, spinal cord injury, or multiple sclerosis, though any disease or trauma that disrupts the central nervous system can trigger it. The condition has been recognized for well over a century, yet it remains difficult to diagnose, hard to treat, and often misunderstood by patients and clinicians alike.
What Causes Central Pain Syndrome
The short list of potential triggers is surprisingly broad. Any event that damages the brain or spinal cord can set the stage: strokes (both from blocked blood vessels and from bleeding), traumatic brain or spinal cord injuries, infections like encephalitis or myelitis, tumors, and demyelinating diseases such as multiple sclerosis. Even a fluid-filled cavity (syrinx) forming inside the spinal cord or brainstem can be enough.1Mayo Clinic Proceedings. Central Neuropathic Pain Syndromes In practice, though, the three causes clinicians see most often are stroke, multiple sclerosis, and spinal cord injury.
What unites all these causes is disruption of the pathways that carry pain and temperature signals from the body to the brain. When those pathways are damaged partway along, the brain does not simply stop receiving signals. Instead, the system often becomes hypersensitive, generating pain in areas that have no tissue injury at all. A person who had a stroke affecting a small region of the thalamus, for instance, may develop burning pain across an entire half of the body, even though the limbs themselves are perfectly intact.
How It Differs from Other Chronic Pain
Many chronic pain conditions involve ongoing tissue inflammation or nerve compression at a specific location. Central pain syndrome is different because the problem lies within the central nervous system itself, not at a peripheral site. The pain is generated by how the brain and spinal cord process signals, not by any damage where the pain is felt. This distinction matters for treatment, because approaches that work for peripheral pain, like anti-inflammatory drugs or local injections, typically have little effect on central pain.
People with central pain syndrome often describe the sensation as burning, aching, or a pins-and-needles feeling that does not let up. Some experience what clinicians call allodynia, where a gentle touch or a light breeze triggers severe pain. Others develop hyperpathia, where a mildly painful stimulus produces an exaggerated, lingering pain response. A key clinical feature, especially after spinal cord injury, is the paradox of losing normal sensation while simultaneously developing abnormal pain perception: the area may feel numb to an ordinary pinprick yet produce searing pain spontaneously.2Spinal Cord. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury
The pain can affect almost any body region depending on where the nervous system was injured. After a thalamic stroke, it often covers the opposite side of the body. After a spinal cord injury, it typically appears at or below the level of the lesion. In multiple sclerosis, the pattern shifts with the location of demyelinating plaques and can come and go with relapses.
Central Pain After Stroke
Central post-stroke pain, sometimes still called the Déjerine-Roussy syndrome after the neurologists who described it in the early twentieth century, is one of the best-studied forms. It tends to follow strokes that damage the thalamus or brainstem, though cortical strokes can also cause it. Pain usually does not start immediately. It can emerge weeks or even months after the stroke, which is part of why it catches patients and doctors off guard.
The clinical picture is not one-size-fits-all. A study of 30 patients with thalamic strokes identified four distinct patterns, ranging from sensory disturbance without pain to severe pain with deep sensory loss to a “pure pain” subtype where touch and joint sensations were preserved yet spontaneous pain was intense.3JAMA Neurology. Thalamic Pain Syndrome of Dejérine-Roussy: Differentiation of Four Subtypes Assisted by Somatosensory Evoked Potentials Data That variability makes the condition easy to miss. A patient whose sensation seems normal on a bedside exam may still have relentless central pain, and a patient with dramatic sensory loss may have no pain at all.
Central Pain in Spinal Cord Injury
Central neuropathic pain is common after spinal cord injury. A longitudinal study found that over half of spinal cord injury patients developed it, with prevalence reaching about 57%.4PubMed. Biomarkers for predicting central neuropathic pain occurrence and severity after spinal cord injury: results of a long-term longitudinal study The pain results from damage to the pathways in the spinal cord that normally relay pain and temperature information upward to the brain.5PubMed Central. Central Neuropathic Pain in Spinal Cord Injury What makes this particularly cruel is the timing: a person may have survived the initial injury, completed acute rehabilitation, and begun adapting to mobility limitations, only to be hit with severe pain that was not present in the first weeks after injury.
The pain often appears in areas below the injury that have lost normal sensation, reinforcing the counterintuitive nature of the condition. You cannot feel a pinch on your leg, but your brain generates a constant burning sensation there anyway. This paradox is a hallmark of central neuropathic pain and reflects the fact that the problem is not at the skin or the nerve endings but in how the spinal cord and brain are processing (or misprocessing) sensory information.
The Role of Multiple Sclerosis
In multiple sclerosis, the immune system attacks the protective myelin coating of nerve fibers. When those attacks hit pathways involved in pain processing, particularly the spinothalamic tract that carries pain and temperature signals, the result can be central neuropathic pain.6PubMed. Multiple sclerosis and pain Lesions that cause hyperexcitability in the central nervous system and disrupt normal pain signaling are thought to account for the continuous burning or aching pain that some MS patients experience in their limbs.7PubMed Central. Neuropathic Pain Secondary to Multiple Sclerosis: A Narrative Review
What sets MS-related central pain apart from post-stroke or spinal cord injury pain is that MS is a relapsing and often progressive disease. New lesions can form over time, potentially worsening pain or changing its location. Conversely, some patients experience pain primarily during relapses, with partial relief during remission. The fluctuating nature can make it harder to find a stable treatment strategy.
Why the Nervous System Starts Generating Pain
Researchers have identified several interacting mechanisms behind central pain syndrome, and the picture that emerges is one of a nervous system that has lost its internal checks and balances.
The most consistent finding is damage to the spinothalamic pathway, the route by which pain and temperature signals travel from the body through the spinal cord to the thalamus and then to the cortex. When this pathway is partially destroyed, the thalamus and cortex do not simply go quiet. Instead, they often become overactive, as if the brain is turning up the volume to compensate for missing input and, in the process, generating pain from noise.
A key piece of this puzzle involves abnormal brain rhythms. In people with chronic neuropathic pain, areas of the brain’s sensory cortex show elevated activity in frequency bands associated with thalamic pacing. One study of patients with orofacial neuropathic pain found that the strength of these altered rhythms in the sensory cortex correlated with how intense the pain was. The study also found that levels of the brain’s main inhibitory chemical in the thalamus were linked to this elevated cortical activity in pain patients but not in healthy controls, suggesting a disruption in how the thalamus normally keeps cortical activity in check.8PubMed Central. The relationship between thalamic GABA content and resting cortical rhythm in neuropathic pain
Neuroinflammation adds another layer. After central nervous system injury, specialized immune cells in the brain and spinal cord called microglia become activated. Once switched on, they release a cocktail of inflammatory molecules, including signaling chemicals that excite nearby neurons and sustain a feedback loop of inflammation and pain.9PubMed Central. Role of Microglia in Neuropathic Pain Activated glial cells in both the spinal cord and brain are now recognized as a central feature of the neuroinflammation that drives chronic pain states.10PubMed Central. Neuroinflammation and central sensitization in chronic and widespread pain This process can persist for months or years, helping explain why central pain syndrome is so stubbornly chronic.
How the Brain Rewires Itself Around the Injury
Beyond immediate damage and inflammation, the brain reorganizes its internal maps in ways that appear to perpetuate pain. After a spinal cord injury, for example, the area of the brain’s sensory cortex that normally receives input from the legs may begin responding to signals from nearby body regions. In one study, spinal cord injury patients showed measurable shifts in their cortical maps, with the brain area for the little finger creeping toward the territory normally reserved for the legs. The degree of this reorganization correlated with how intense the patient’s ongoing pain was.11PubMed. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury
This kind of cortical reorganization is not limited to peripheral nerve injuries. Research has shown that it also occurs in patients with chronic neuropathic pain who have no peripheral nerve damage at all, suggesting that the rewiring may be a consequence of chronic pain itself, not just the injury that triggered it.12PubMed. Cortical reorganization in primary somatosensory cortex in patients with unilateral chronic pain That finding raises an unsettling possibility: central pain syndrome could become self-sustaining, with the brain’s attempt to adapt to lost input fueling the very pain it is trying to make sense of.
Why Diagnosis Is Often Delayed
Central pain syndrome has no definitive lab test, blood marker, or imaging finding. Diagnosis rests on clinical criteria: a history of central nervous system injury, pain that matches the territory of the damaged pathway, and sensory abnormalities consistent with that injury. In theory, that sounds straightforward. In practice, it frequently goes wrong.
One reason is timing. Because the pain often appears weeks to months after the triggering event, neither the patient nor the treating physician necessarily connects the new symptom to the old injury. A stroke survivor may attribute new arm pain to a musculoskeletal problem rather than a delayed neurological consequence of the stroke. Another reason is the paradoxical combination of numbness and pain. Patients sometimes struggle to articulate that an area that feels numb also hurts, and clinicians may dismiss pain in a region where sensation testing seems impaired.
Quantitative sensory testing, which systematically measures thresholds for detecting heat, cold, pressure, and vibration, can help characterize the sensory abnormalities, but it is time-consuming and not widely available outside specialized pain clinics. The condition was first described in 1891 and remained, by one expert review’s account, “an obscure neurological syndrome with no explanation or effective treatment” for much of the time since.13PubMed. Central pain syndrome: elucidation of genesis and treatment While understanding has improved considerably, the historical neglect means that many generalist physicians still have limited familiarity with the condition.
Predicting Who Will Develop Central Pain
Not everyone who sustains a stroke or spinal cord injury develops central pain. Researchers have been working to identify early signs that could predict who is at risk. In a longitudinal study of spinal cord injury patients, those who eventually developed central neuropathic pain showed reduced ability to adapt to ongoing pain and diminished conditioned pain modulation (the body’s built-in pain-dampening system) early after injury. These early markers predicted central pain emergence at three to four months and seven to eight months after injury, with the best predictor carrying roughly a 77% probability of identifying future pain development.14PubMed. Biomarkers for predicting central neuropathic pain occurrence and severity after spinal cord injury: results of a long-term longitudinal study
The presence of allodynia early on and impaired pain modulation also predicted how severe the pain would become over the following two years. If these findings hold up in larger studies, they could eventually allow clinicians to identify high-risk patients shortly after injury and intervene before central pain becomes entrenched. That is still an aspiration rather than standard practice, but the research represents a genuine shift from reactive treatment toward early prediction.
Treatment Challenges and Options
Central pain syndrome is notoriously difficult to treat. Standard painkillers, including over-the-counter options and even many prescription medications, tend to be ineffective. The reason is fundamental: the pain is not generated by tissue inflammation or peripheral nerve irritation, so drugs designed for those mechanisms miss the target.
First-line pharmacotherapy typically involves medications originally developed for epilepsy or depression that happen to modulate nerve signaling. Pregabalin, an anticonvulsant, has shown effectiveness comparable to its performance in peripheral neuropathic pain conditions and is one of the recommended drugs for central pain.15Neuropsychiatric Disease and Treatment. Clinical use of pregabalin in the management of central neuropathic pain Gabapentin, a related anticonvulsant, and certain antidepressants that affect both serotonin and norepinephrine are also commonly tried. But the honest reality is that many patients get only partial relief, and side effects like drowsiness, dizziness, and cognitive dulling can be significant.
Opioids, which are potent painkillers for many types of pain, tend to be less effective for central pain. This makes sense given the mechanism: the problem is not a peripheral pain signal that opioids can intercept but a central processing error. For refractory cases, subanesthetic doses of ketamine, an anesthetic drug that blocks a different receptor involved in pain amplification, have been explored. Randomized controlled trials have investigated ketamine for central neuropathic pain, though its use remains limited to specialist settings because of side effects and the logistics of administration.16PubMed Central. Ketamine for chronic pain: risks and benefits
Brain Stimulation Approaches
When medications fail to provide adequate relief, clinicians increasingly look to techniques that modulate brain activity directly. These fall into two broad categories: non-invasive approaches that work through the skull, and surgical approaches that implant electrodes.
Repetitive transcranial magnetic stimulation (rTMS) is the most studied non-invasive option. A coil held against the scalp generates brief magnetic pulses that stimulate neurons in the underlying brain tissue. High-frequency stimulation of the motor cortex has moderate evidence of reducing pain in central post-stroke pain and other neuropathic pain conditions.17PubMed Central. Repetitive transcranial magnetic stimulation in central post-stroke pain: current status and future perspective The relief tends to be temporary, lasting days to weeks after a course of sessions, which means repeated treatments are often necessary. Still, for patients who respond, it offers a way to reduce pain without the systemic side effects of medications.
For more severe, medication-resistant cases, surgical neuromodulation is an option. Motor cortex stimulation (MCS) involves implanting electrodes on the surface of the brain over the motor cortex, while deep brain stimulation (DBS) places electrodes in structures deep within the brain, typically the thalamus or periventricular gray matter. A systematic review and meta-analysis of these approaches for central post-stroke pain found that about 62% of patients who underwent DBS and 64% who underwent MCS showed improvement, with average pain score reductions of roughly 49% and 53%, respectively.18PubMed Central. Deep brain stimulation and motor cortex stimulation for central post-stroke pain: a systematic review and meta-analysis Another review reported pain improvement ranging from 35% to 80% in MCS patients and 50% to 60% in DBS patients.19PubMed. Neuromodulation for Medically Refractory Neuropathic Pain: Spinal Cord Stimulation, Deep Brain Stimulation, Motor Cortex Stimulation, and Posterior Insula Stimulation These are meaningful improvements for people whose pain has resisted everything else, though the surgery carries risks and responses vary widely between individuals.
Virtual Reality and Experimental Approaches
Given that cortical reorganization appears to contribute to central pain, researchers have asked whether feeding the brain corrective sensory information might help reverse some of those changes. Virtual reality (VR) is one tool being explored for this purpose, particularly after spinal cord injury. The idea is that visually representing a body part moving in a virtual environment could influence sensory processing in the brain, potentially reducing pain.
A scoping review of VR for neuropathic pain in spinal cord injury patients found that visual stimulation of a body part within a VR environment is hypothesized to improve sensory outcomes.20PubMed Central. Virtual reality for the treatment of neuropathic pain in people with spinal cord injuries: A scoping review The evidence is still early-stage, with small studies and short follow-up periods, so VR is far from being a proven treatment. But the approach is interesting precisely because it targets the brain’s remapping process rather than trying to dampen pain signals chemically.
Other experimental approaches include closed-loop neurostimulation systems that adjust stimulation in real time based on brain activity, and investigations into specific neuroinflammatory targets that might allow more precise drug treatment. The broader direction of the field is toward personalized strategies: figuring out which of the several mechanisms is dominant in a given patient and tailoring treatment accordingly, rather than cycling through the same sequence of medications for everyone.
Living with Central Pain Syndrome
Beyond the physical pain itself, central pain syndrome has far-reaching effects on daily life. Sleep disruption is common, because the pain does not turn off at night. Depression and anxiety frequently accompany the condition, driven partly by the pain itself and partly by the frustration of having a condition that is hard for others to see or understand. Research on central sensitization in chronic pain more broadly has found strong links between sensitization, sleep quality, depression, and disability, each feeding the others in a cycle that is hard to break.21PubMed Central. Neuroinflammation and central sensitization in chronic and widespread pain
Rehabilitation for central pain syndrome usually involves more than just medication. Cognitive behavioral therapy can help patients manage the emotional and psychological dimensions of chronic pain. Physical therapy, even when it cannot directly reduce the pain, helps maintain function, prevent deconditioning, and preserve the sense of agency that chronic pain can erode. Occupational therapy may address practical challenges in daily activities that pain makes difficult.
One of the hardest aspects for many patients is the invisibility of the condition. There is no cast, no scar, no visible sign. Family members and coworkers may not understand why someone who “looks fine” is struggling. The delay between the original injury and the onset of pain compounds this: people expect recovery to be linear, and the appearance of a new, disabling symptom months later can feel like a bewildering setback. Patient education and support groups, while no substitute for effective treatment, play a real role in helping people make sense of their condition and advocate for the care they need.